JPMorgan Chase & Co’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $96.4K | Sell |
|
|||||
|
2025
Q2 | $94.7K | Sell |
|
|||||
|
2025
Q1 | $1.02M | Sell |
|
|||||
|
2024
Q4 | $11M | Buy |
|
|||||
|
2024
Q3 | $192K | Buy |
|
|||||
|
2024
Q2 | $160K | Buy |
|
|||||
|
2024
Q1 | $509 | Hold |
|
|||||
|
2023
Q4 | $194 | Sell |
|
|||||
|
2023
Q3 | $178 | Hold |
|
|||||
|
2023
Q2 | $185 | Hold |
|
|||||
|
2023
Q1 | $0 | Sell |
|
|||||
|
2022
Q4 | $37K | Buy |
|
|||||
|
2022
Q3 | $36K | Sell |
|
|||||
|
2022
Q2 | $88K | Buy |
|
|||||
|
2022
Q1 | $52K | Sell |
|
|||||
|
2021
Q4 | $845K | Buy |
|
|||||
|
2021
Q3 | $688K | Buy |
|
|||||
|
2021
Q2 | $151K | Buy |
|
|||||
|
2021
Q1 | $150K | Sell |
|
|||||
|
2020
Q4 | $205K | Buy |
|
|||||
|
2020
Q3 | $144K | Buy |
|
|||||
|
2020
Q2 | $173K | Buy |
|
|||||
|
2020
Q1 | $5K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $114K | Sell |
|
|||||
|
2019
Q1 | $372K | Sell |
|
|||||
|
2018
Q4 | $422K | Sell |
|
|||||
|
2018
Q3 | $823K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $37K | Sell |
|
|||||
|
2017
Q4 | $228K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $15K | Buy |
|